Duchenne Muscular Dystrophy: Diagnosis, Treatment, and Emerging Therapies

Ikena Oncology and Inmagene Biopharmaceuticals Announce Merger to Form ImageneBio

Fujirebio and Eisai Partner to Advance Diagnostics for Neurodegenerative Diseases

European Commission Approves Opdivo® Plus Yervoy® for First-Line Treatment of MSI-H or dMMR mCRC

Deerfield Management to Acquire Singular Genomics for $20 Per Share in All-Cash Deal

EU Approval of Tagrisso Sets New Standard for EGFR-Mutated NSCLC Treatment

Aurobindo Pharma’s Subsidiary CuraTeQ Secures UK Approval for Bevacizumab Biosimilar

SCG Cell Therapy Partners with A*STAR BTI and NATi to Advance RNA-Based Therapeutics

Korea's National Bio Big Data Project: Advancing Precision Medicine with Macrogen and Illumina

GST Exemption Announced for Cancer Treatment Gene Therapy

AIIMS Develops Affordable CAR-T Cell Therapy for Multiple Myeloma

Sangamo Therapeutics and Astellas Collaborate on Innovative Gene Therapy for Neurological Diseases

FDA Clears IND for Arbor Biotechnologies’ ABO-101 Gene Editing Therapeutic for Primary Hyperoxaluria Type 1

Fortis Healthcare Acquires Stake in Agilus Diagnostics

FDA Approves BRAFTOVI® Combination Regimen as First-Line Treatment for BRAF V600E-Mutant Metastatic Colorectal Cancer

Home
/
update
/
details

Qure.ai Wins Siemens Healthineers Startup Award 2024 for Advancing Healthcare AI Innovation

NextEdge Admin

12 Aug 2024

2 min 4 sec

Qure.ai, a global leader in healthcare AI, has been honored with the Siemens Healthineers Startup Award 2024. This prestigious accolade celebrates startups that have developed innovative and impactful solutions to healthcare challenges, showcasing strong growth and market potential. Qure.ai's AI-driven technologies have significantly advanced the diagnosis of tuberculosis, stroke, and musculoskeletal conditions, contributing to improved patient outcomes.

Prashant Warier, CEO and Co-founder of Qure.ai, expressed pride in receiving the award and emphasized the value of their partnership with Siemens Healthineers. “To be recognized as a leading innovator in AI-powered healthcare by Siemens Healthineers is a tremendous honor. Their commitment to improving patient outcomes and access to care aligns perfectly with our mission,” he stated. Warier also highlighted the collaboration's potential to enhance access to healthcare and streamline diagnostics globally.

Peter Schardt, Chief Technology Officer at Siemens Healthineers, praised the partnership, noting, “Together, we are accelerating the transformation of smart ideas into impactful healthcare solutions. This award celebrates the exceptional team at Qure.ai, who are driving a healthier future for all.”

Qure.ai’s collaboration with Siemens Healthineers underscores a shared commitment to making healthcare more accessible, equitable, and sustainable worldwide. The award is a testament to Qure.ai's innovative contributions and its potential to continue revolutionizing healthcare through AI-powered solutions.